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Abstract

Data management and data facilitation is the foundation and a critical part for
scientific investigations, especially with large cohort studies on health care, which
may have multiple components collected from different institutes or different areas
due to efficiency, cost, enrollment considerations. In this thesis, I consider how to
design and to implement data management with multi-center health care research
data. The research project that I joined focuses mainly on environmental health
science, and the primary goal is to investigate the impact of nutritional and toxicant
exposures in environment during fetal and early postnatal life on individual’s health
outcomes over the life course. More specifically, I will present my work in a newly
established research project, ECHO (Environmental Influences on Child Health
Outcomes), on designing the data management plan and program codes for the data
management and modeling core, facilitating and accomplishing data communication,
cleaning and unifying data labels and formats, preparing datasets to achieve
desirable data structures for further statistical analysis, and controlling data quality to
ensure the overall research quality.
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Chapter 1. Introduction

1.1 Background and Significance
Basic and social sciences have independently advanced conceptual frameworks
grounded in a developmental paradigm as a basis for understanding how early life
exposures influence health over the life course. However, social and chemical
exposures are not independent of each other. It is important to investigate not only
the direct effects but also the interactions of social context and chemical exposures at
key developmental periods as the health scientists try to understand how these confer
to long-term susceptibility to obesity and adverse neurodevelopmental outcomes.
The ‘developmental origins’ hypothesis postulates that nutritional and toxicant
exposures during fetal and early postnatal life influence developmental plasticity
through epigenetic mechanisms, altering susceptibility to chronic conditions in later
life [1]. The Environmental Protection Agency (EPA) incorporated the concept of
life stage exposures into its risk assessment and regulatory framework [2, 3],
recognizing that exposures during vulnerable periods may affect health outcomes
that do not manifest until many years later. In their influential article on critical
windows of toxicant exposure, Selevan, et al.[4] noted that research on exposures in
utero is more advanced than that considering adolescence, a biologically vulnerable
period characterized by hormonal changes and maturation of many organ systems.

1	
  

Perspectives from public health and social sciences underscore the relevance of
multi-level influences during the perinatal and pubertal periods as well as other key
developmental stages, including the transition from early to mid-childhood and from
adolescence to young adulthood.
There has been a large body of literature working on environmental health, which
has advanced the concept of the “exposome” that echoes developmental paradigms
in basic and social sciences. At its essence, the exposome is the environmental
equivalent of the genome and encompasses all lifetime exposures including
chemical, lifestyle, dietary and other physical influences. Multiple definitions exist
[5-8], all highlighting the broad range of exposures that may shape health and
disease across the life course. Improving detection of internal biomarkers of
exposure and response is an area of rapid technological development, but
approximating the entire exposome may be decades away [6, 9]. Integrating data on
biological responses to social and chemical exposures across multiple developmental
time periods is essential to develop a more complete picture of the exposome.
Understanding how biologic responses to exposures may impact obesity, cognition
and behavior requires, nevertheless, the selection of mediators that reflect change
across developmental trajectories. Current evidence links social and toxicant
exposures during discrete developmental windows to risk of obesity and/or poor
neurocognitive health. Few birth cohorts with repeat toxicant exposures over
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sufficient length of follow-up also collect nuanced measures of socioeconomic status
(SES) and parenting. Thus, our ability to understand how interactions of social
context with chemical exposures may affect neurodevelopment and risk of obesity
and metabolic squeal during multiple sensitive periods is limited. To address these
challenges, a multi-center large cohort study has been proposed by leveraging the
research infrastructures and data from environmental influences on Child Health
Outcomes (ECHO). This study is a multi-center large cohort study, which includes
three specific study cohorts: the Fragile Families and Child Wellbeing Study (FF),
Early Life Exposures in Mexico to Environmental Toxicants study (ELEMENT),
and Center for Oral Health Research in Appalachia study (COHRA). This
dissertation work is mainly focusing on data management and data facilitation in this
multi-center large cohort study. Below, I will introduce specifically more details of
ECHO data management and each ECHO study cohort.

1.2 ECHO DMMC and ECHO study cohorts
ECHO (environmental influences on Child Health Outcomes) is a multi-center
research investigation proposed to understand how the social and chemical
environment is associated with the biophysiologic mediating mechanisms and how it
may affect the obesity-related and cognitive outcomes from fetal life through the
transition to young adulthood. This study involves four research institutes and
collected data from three study cohorts with repeated measurements measured
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longitudinally. The Fragile Families study has 925 participants; the Early Life
Exposures in Mexico to Environmental Toxicants study has 800 participants; and the
Center for Oral Health Research in Appalachia study has 1280 participants.
My work belongs to the data management and modeling core (DMMC) of ECHO.
My primary goal is to provide high quality data management on these 3005 children
to further enable scientific discovery, and to organize data ultimately useful in
informing evidence-based interventions. In the research plan of ECHO, a sub-cohort
of 200 participants from ELEMENT study and FF study will obtain richly
characterized intergenerational exposure measures, including exposome and
epigenome data. Each of the three studies has already collected large amounts of
high quality, validated data on a broad set of areas. For example, all three studies
already have measures of obesity, neurodevelopment, social variables, and so on.
ECHO will collect new data, and further harmonize a variety of data across the three
study cohorts: FF, ELEMENT, and COHRA.
The Fragile Families and Child Wellbeing Study (FF) is a landmark, nationally
representative child development study of the effects of poverty, parenting and other
social exposures on child health, obesity, cognitive and social development, school
readiness, and academic achievement. The Early Life Exposures in Mexico to
Environmental Toxicants (ELEMENT) is an award-winning cohort study, where the
chemical exposures of ELEMENT participants have been characterized from the
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prenatal period, and the health outcomes of interest include cognition, behavior,
sexual maturation and an array of obesity-related outcomes, including metabolomics;
the Center for Oral Health Research in Appalachia (COHRA) study is collecting a
unique cohort of mother-infant pairs from northern Appalachia to evaluate the
factors predisposing to disproportionately high rates of poor oral health.
I am mainly involved in the ECHO data Management and Modeling Core (DMMC).
ECHO DMMC plays a central role of liaison in coordinating and giving updates on
the progress of data collection, data QC, data transfers, and data analysis results, and
publications among cohorts. Professional data mangers and statisticians handle the
data analysis part. In this dissertation, I designed a data management plan for ECHO
DMMC. Since not all the data are available yet and some sub-studies are still
collecting data, my major focus is on data processing from the ELEMENT study to
illustrate how the data management and data organization process as proposed work.
My main responsibilities in this work include data management, data integration, and
data harmonization, which will handle parts of the existing databases from
ELEMENT, COHRA and FF studies and new data to be collected to address
ECHO’s proposed scientific aims. My focus is to design a data management plan
and provide some strategies to establish the centralized data coordination handling
data inquiries pertaining to database from two or more cohorts, while individual
cohort databases are stored in separate study sites. The data management strategies
we are working on can maximally utilize the existing data management
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infrastructure to support the ECHO proposed research activities. Specifically, I
designed both online data require form and feedback form to facilitate data
communications. I wrote the SAS [10-16] codes to implement data harmonization,
data quality control (QC), and data transfer. SAS is one of the most popular
statistical software. In this thesis work, I especially focused on SAS data process,
SAS PROC IMPORT/EXPORT, SAS PROC SQL and some basic SAS STAT
procedures. My work contributes to the goal of the part of ECHO DMMC, which is
to manage all raw lab data including data storage, data QC and data transfer. Since
the data are collected by different staffs at different research institutes, each institute
may have multiple sites to enroll patients, each sub-study may include several waves
of patients with data collected at different times, different ages, and repeated
measures are collected over the time longitudinally, as one can imagine, one of the
key functions of our DMMC is the coordination among the existing individual
cohort data management teams, and integration of meta data and data elements
needed for the proposed study aims. My work in this dissertation covers all of these
aims, with a major focus on the multiple sub-cohorts in ELEMENT study. I will
illustrate the data management process and some data analysis process through a
research investigation on how prenatal and childhood lead exposure affect
adolescent’s sexual maturation.
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1.2.1 The Fragile Families and Child Wellbeing Study (FF)
The Fragile Families and Child Wellbeing Study (FF) is a landmark, nationally
representative child development study of the effects of poverty, parenting and other
social exposures on child health, obesity, cognitive and social development, school
readiness, and academic achievement.

This birth cohort study enrolled

approximately 4900 children born in large U.S. cities between 1998 and 2000. The
study includes: (1) interviews with mothers and fathers at birth and again when
children are 1, 3, 5, 9 and 15 years old; (2) medical records for a subset of mothers
and children at birth; (3) in-home assessments of children and home environments
when children are 3, 5, 9 and 15 years old; (4) interviews with children at age 9 and
15; (5) interviews with teachers when children are 3, 5, and 9 years old; and (6)
saliva DNA samples from mothers and children when children are age 9 and 15, and
neuroimaging data from a subset of children at age 15. When the corresponding
sampling survey weights, the data are representative of all births in all US cities with
populations of 200,000 or more. Additional weights make the data representative of
births within each city [17]. Response rates for mothers at baseline, calculated as a
percentage of eligible births, are 86% at year 1, 3, 5, 9, 15 interviews, and for
children, calculated as a percentage of eligible respondents at each wave, are 90, 88,
87, 76, 91% respectively. Response rates for DNA at the year 9 interview are 85%
for children and 79% for mothers; current age 15 response rates appear slightly
higher. ECHO plans to collect a new wave of assessments, including blood and urine
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collection on three of the twenty cities involved in FF (n=925): Detroit, Michigan
and Oakland and San Jose, California. These three cities were chosen because they
are in states that afford access to neonatal bloodspots. All participants were recently
or are currently being interviewed at age 15. By the start of planned data collection
the oldest would be 20 years old. Birth and early life outcomes will also be collected
for the children of female FF participants. Of the approximately 430 females in the
original sample for these three cities we conservatively expect approximately 175
births throughout the entire project timeline based on the race (10% non-Hisp white,
47% Black, 45% Hispanic, 3% other), SES (30% <100% the Federal Poverty line
(FPL), 35% 100-200% FPL, 35% 200%+ FPL) and Age (Mom participants will be
19-24 during the data collection period).

1.2.2 The Early Life Exposures in Mexico to Environmental Toxicants
(ELMENT)
The Early Life Exposures in Mexico to Environmental Toxicants (ELEMENT) study
comprises three sequentially-enrolled epidemiologic birth cohort studies in Mexico
city with the original aim of investigating the influence of lead exposure on various
outcomes related to fetal and infant development. Pregnant women were recruited at
maternity clinics of the Mexican institute of Social Security: Cohort 1 was recruited
from 1994 to 1997; Cohort 2 from 1997-2001; and cohort 3 form 2001 to 2005. In
2006-2012, study continued follow-up of all 3 cohorts to assess the impact of
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prenatal lead exposure on neurobehavioral outcomes with specific attention to
genetic influences of cholesterol metabolism genes. Figure 1 below shows the data
collection procedure and the timelines.

Figure 1. Data collection procedure over time and the three waves of study
cohorts of the ELEMENT study.

All three ELEMENT cohorts have the same source of subjects (maternity clinics),
eligibility criteria and methods when evaluating both fetal and postnatal toxicant
exposures, covariates and outcomes. ELEMENT participants are generally low to
middle-class and representative of the general population in Mexico City. All three
cohorts of ELEMENT have archived biological samples that have been wellvalidated for chemical analysis and retrospective exposure assessment, a deliberate
strategy to ensure the comparability of these subjects and associated data. Our work
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will further organize the ELEMENT data in a better way and easily allow us to pool
data across the ELEMENT population to address new scientific investigations. The
ELEMENT study has been very successful, with its rigorous study design,
outstanding follow-up rates and multidisciplinary expertise of their team,
ELEMENT study group has generated over 60 international publications, including
high impact research on cognitive outcomes related to prenatal exposures to lead
[18-20] and gene-environment interactions [21]. Evidence from ELEMENT studies
has informed U.S. lead exposure guidelines including many recent new policy
statements [22-25]. The current outcomes collected in ELEMENT study include
cognition and behavior in mid-childhood, obesity and metabolic outcomes including
metabolomics in peripuberty as well as sexual maturation of physician-observed
Tanner staging and hormone assays. The careful collection and storage of biological
samples has allowed the study team to use archived samples to retrospectively assess
a variety of exposures in the studies of the toxicity of manganese, bisphenol A,
phthalates, and mercury and so on. Thus, the ongoing funding related to ELEMENT
has enabled continued follow-up of participants, to assess the impact of EDC
mixtures and their interaction with diet on growth, maturation and metabolic
outcomes via epigenetic mechanisms. Potentially, a new wave of assessments,
including structural brain MRIs at one time point will be collected on 800
ELEMENT participants currently aged 9-17 years. When combined with the other
existing assessment collections of ELEMENT, these 800 participants will each have
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at least two assessments during the transition late adolescence into young adulthood.

1.2.3 The Center for Oral Health Research in Appalachia (COHRA)
The Center for Oral Health Research in Appalachia (COHRA) study collected a
unique cohort of mother-infant pairs from northern Appalachia to evaluate the
factors predisposing to disproportionately high rates of poor oral health. COHRA
applies a rigorous multidisciplinary strategy to understand the interrelated factors
leading to poor oral health in Northern Appalachian children. To achieve this, a
child- and family-centric study design is employed to combine assessments of
individuals—their genomes and their personal “environments” (e.g., oral health
status, oral microbiome, diet, behavior), with family- and community-level variables.
The ultimate objective of COHRA is to determine targets for interventions that can
alter the oral health trajectory begun in infancy, thus potentially improve oral health
throughout life.
COHRA has recruited two samples from West Virginia and western Pennsylvania:
COHRA1, a cross-sectional cohort of nuclear families (recruited from 2003 – 2009;
[26]), and COHRA2, a longitudinal cohort of healthy mother-baby pairs recruited
during pregnancy and followed until the children are at least age six (recruited from
2012-present). Trained and calibrated dental hygienists see the COHRA2 women
and their children at least yearly, beginning before the children are born. In addition,
the University of Pittsburgh Center for Social and Urban Research (UCSUR)
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administers an extensive phone questionnaire to all women every six-months. New
recruitment is ongoing, as are longitudinal follow-up protocols.
COHRA has produced many high quality peer-reviewed publications, which include
the first GWAS of any dental disease—dental caries in the primary dentition [27].
COHRA data are part of the GLIDE consortium study of periodontal health and BMI
[28], and also investigated the effect of sibship and caries status on the salivary
metabolomes of sib pairs with different levels of dental decay [29], caries resistance
as a function of age [30], demographic, SES, and behavioral factors [31], the nature
of dental fear and/or anxiety [32, 33], sex differences in caries susceptibility [34, 35];
gene-environment interaction between enamel matrix genes and fluoride exposure
[36], a gene-gender interaction [37], a gene-smoking interaction in periodontal
disease [39], interaction between depression and rurality for several oral health
indicators [39], and etc.
Continued follow-up are planned on 1280 current COHRA participants and
additional assessments will be collected at 5 and 8 years to coincide with sensitive
developmental periods for obesity and cognition and socioemotional behavior, as
well as measures of these outcomes and to provide comparable data on exposures
(e.g., with the ELEMENT study).
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1.3 Data Management Plan
Since this is a multi-center large health care studies cohort, our data management
and modeling center plays a central role in coordinating and providing updates on
the progress of data collection, data QC, data transfers, and data analysis results
among cohorts.

Figure 2. The flow chart of ECHO studies, ECHO data, and their connections
with our data management and modeling core.

One of ECHO DMMC main role is to handle data management, integration and
harmonization. FF, ELEMENT, and COHRA studies currently maintain databases
that contain data elements beyond the scope ECHO-DMMC. Hence, the data
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managed as part of this ECHO- DMMC includes parts of the existing databases from
FF, ELEMENT, and COHRA and new data collected to address the proposed
scientific investigations. The ECHO DMMC will lead centralized coordination to
handle data inquiries pertaining to data from two or more cohorts, while individual
cohort databases are stored in separate study sites. In this way, the existing data
management infrastructure will be maximally utilized to support the newly proposed
research activities, and not duplicated in the ECHO DMMC. The ECHO DMMC
will manage all data required to address the specific study aims, including data
storage, data QC and data transfer of newly collected data, and data harmonization of
existing data elements. To maximize efficiency, each cohort-specific DMMC will be
responsible for managing new questionnaire-based data from the existing cohortspecific participants, which will then be combined by the ECHO DMMC for
analysis. The ECHO DMMC will manage all raw lab data including data storage,
data QC and data transfer. Figure 2 present an organizational chart in which one of
the key functions of the ECHO DMMC includes the coordination among the existing
individual cohort data management teams, and integration of meta data and data
elements needed for the proposed study aims.
Each individual cohort DMMC will include faculty statistician, a database manager
and an analyst, covering basic data management needs, including integrating new
data to be collected in this proposal to the cohort- specific databases, and basic data
analysis of each cohort. These personnel already thoroughly understand the data
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structure and contents of the individual cohorts and will also have key
responsibilities related to data harmonization and integration for the ECHO projects.
They will collaborate with the ECHO DMMC to create and maintain the overall data
dictionaries and to extract and transfer any requested data used to fulfill analysis
goals of the current proposal. As needed, each individual cohort DMMC will
conduct data analysis of cohort- specific data and develop or apply statistical models
needed to fulfill analytic needs related to this proposal. In terms of coordination,
each individual cohort DMMT will be responsible to inform the ECHO DMMC of
any updates and progress on data collection, data validation, data analysis results and
publications for each project. In addition, the sharing of statistical models and
methods used in cohort- specific analysis will be communicated with the statisticians
serving the other cohorts.
Professional data mangers and statisticians handle the data analysis part. For the part
of data inquiry and communication, data harmonization and documentation, and data
quality control defines my training spectrum and thesis. I ensure that dataset is
adequately prepared with the appropriate variables in SAS format for further data
analysis, and get the data easily understood by both research investigators
(clinicians, medical professionals, professors, and researchers) and statisticians
(those who perform data analysis). The major procedures that I used in SAS to deal
with data management include SAS data process, SAS PROC IMPORT/EXPORT
and SAS PROC SQL. I will also perform some basic analysis to ensure data quality
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control and provide fundamental statistics using SAS stat procedures.
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Chapter 2. Data Communication
As we have seen from the introduction in Chapter 1, this is a typical large cohort
study with data collected at multiple locations, during multiple study waves, and at
multiple longitudinal time points. To facilitate the communication between scientific
investigators and the data management group, we design data request forms and data
feedback forms for people who are interest using our existing meta database for
further scientific investigations. At the same time when our data management group
is preparing the desired data structure and dataset for further analysis, we need pay
attention to the security when transferring data, and especially when connecting to
different database servers at remote locations. After this, we dynamically modify and
follow-up data communication online request form to allow more convenience and a
more systematic data management procedure. Furthermore, we need to establish the
appropriate notice and data documentation, which help explain the data usage right
and permission.

2.1

Semi-automatic online data request process

According to what is potentially related to people’s interest, and after several data
process procedures handled manually face to face with the study team, I found it
would be more efficient if we can develop some semi-automatic procedure for data
request before face to face meetings. This will help both the scientific investigators
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and the data manager to make things clarified, documented, and in the meanwhile
save a lot of time from travelling to meetings.

The welcome page describes what this website is for, and you can find brief
descriptions of the existing raw data structures and raw data contents. Along with this
welcome page, I also provide some guidelines for the data file that will be generated
by our data management group. For example, where are the variable names, how to
code missing data, where to find the detailed data dictionary, and what the data
dictionary contains, and some common coding of the demographics variables.

Welcome to our DMMC (Data Management and Modeling Core)!
You can request a dataset by providing the following information. We will
prepare the dataset accordingly, along with our priority list. It may take a few
days, but we will send it back to you as soon as the dataset is ready.
Please note some guidelines for data structure as you receive the requested
dataset:
1. The first row contains a variable name.
2. Missing data are coded as NA.
3. Each data will come with a detailed data dictionary, including what each
variable means, the units of continuous measurements, the value of each level
for categorical variables, etc
4. Some common coding for demographics variables:
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1) Gender: female=0, male=1
2) Race: 1=White 2=African American 3=Hispanic 4=Other
3) education level: 1=high school or less 2=two year college 3=four year
college 4=post graduate degree

Then the investigator will complete the online questionnaire regarding the study they
propose to investigate. Thus, we at the DMMC will know what variables from which
cohort may potentially be of their study interest. We will merge and recreate new
dataset for the investigators to use according to their need. Some sample survey
questions are:

Which of the following databases do you need to use?
( ) Fragile Families (DMMC) include about 15 years data
( ) ELEMENT (DMMC) include about 20 years data which is
related to chemical element
( ) COHRA (DMMC) include about 10 years data which is
related to children's oral health
( ) Other database (please specify)
What is your project title?
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Main Scientific Objective?
Principal Investigator:
Specific Scientific Questions (please enumerate):
Outcome (dependent variable):
Predictors (independent variables):
Potential Confounders:

This semi-auto data request form can be completed online at the DMMC website,
and the completed form will be automatically sent to a specific data manager’s
mailbox. Once ECHO DMMC receives the completed data request form, ECHO
DMMC manager will go over all existing raw data files and locate the appropriate
study cohort(s) correspondingly, and then organize a new dataset or several datasets
if needed according to years or other specified data request requirements. This semiauto procedure can be done easily and quickly without too much interactions
between personnel. Following this step, the investigator and the data manager can sit
down and meet in person or over the phone with the semi-auto prepared dataset(s) of
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their potential interest in front of them and see if they need to modify, further
generalize or detailed tailoring of the data.

2.2 Securely transfer data and privacy protection
For complex computer world, hackers are more techs savvy and can infiltrate
networks by exploiting vulnerabilities. Especially in the case when people’s health
care data are involved, it is very important to ensure data security and privacy
protection. For ECHO DMMC, we consider the following methods that can help us
achieve the aim of keep data security and confidential data privacy. First, before
manipulating data for further structure changes, we make a copy of the raw data and
safely save raw data with password protections, and even on private computer/server
isolated from any Internet or other user use. Secondly, when carrying out the
processing procedure, we always set safe password for connection servers. For
example, with any remote connection to different locations when searching data, we
always use SAS secure link/connections with password saved in a separate file
directory. Another idea is setting encryption competence measure for ECHO DMMC
data manager.

2.3 Data follow-up communication
The semi-auto process has been in use since I developed the online request form on
their website this summer. Several studies have been proposed and got the dataset
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generated by that way. We further developed a series of follow-up communications
between data manager and scientific investigators to monitor the data creating
process, data safety issues, and collect feedbacks from both sides on how to improve
the process.

2.4 Data use permission and agreement
As many other study/protocol/grant, a data use permission and data use agreement
(DUA) is necessary to ensure data safety and data privacy during the transfer of data,
especially when the data is nonpublic or is otherwise subject to some restrictions on
its use. Typically, this is a contractual document on the agreements that is required
under the Privacy Rule and must be entered into before there is any use or disclosure
of a limited dataset to an outside institution or party. Like in our study, any data
created by our data management group is a necessary component of the research
project and it does contain human subject data. So the institutes involved in ECHO
want to ensure that DUA terms protect confidentiality when necessary, but permit
appropriate publication and sharing of research results in accordance with University
policies, applicable laws and regulations, and federal requirements. Therefore, the
team established the corresponding data use permission and agreement to help
restrict the use and disclosure of the data set, and, under these restrictions, our
DMMC team prepare and unify the format of newly created datasets in the form
appropriate for the transfer of data.
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Principal Investigator (PI) creates and submits the data request in the secure intranet
online system. To avoid any delays in processing, the PI/PI's department should
ensure that the PI has completed his/her annual Conflict of Interest (COI) disclosure
using the Faculty/Researcher form. Upon electronic receipt of a new submission, the
project coordinator will begin initial submission review and will contact the PI or
their administrative contact if any of the required documentation is missing or
incomplete. Then data use agreement will be circulated for signatures. When all of
the required documentation has been received completely, the data request will be
assigned and forwarded to a data manager at DMMC officer for review and data
preparation. The data use permission and agreement file may include the
components similar as follows:
•

Establish the permitted uses and disclosures of the limited data set;

•

Identify who may use or receive the information;

•

Prohibit the recipient from using or further disclosing the information, except
as permitted by the agreement or as otherwise permitted by law;

•

Require the recipient to use appropriate safeguards to prevent an
unauthorized use or disclosure not contemplated by the agreement;

•

Require the recipient to report to the covered entity any use or disclosure to
which it becomes aware;
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•

Require the recipients to ensure that any agents (including any
subcontractors) to whom it discloses the information will agree to the same
restrictions as provided in the agreement; and

•

Prohibit the recipient from identifying the information or contacting the
individuals.
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Chapter 3. Data Harmonization, Data preparation, and
Data documentation
In this chapter, I will present details about the data process procedure that I have
done every time I receive a data request. Following by the data request form, I will
locate what parts of the whole data collection can be used to establish the specific
scientific investigation according to their main scientific objectives and specific
scientific questions. They mainly have listed their targeted outcome and potential
predictors and confounds that they want to include. I will also go through the whole
study and see if there is anything they may have missed and will add in, just for their
potential interest. After I located every piece and where they are saved in the raw
datasets, I will employ SAS DATA process, SAS PROC IMPORT/EXPORT, and
SAS PROC SQL to perform Data Harmonization and Data preparation. I will also
use both SAS and Word to prepare the corresponding Data archive files and Data
documentations. In the following, I will mainly focus on the data management in
ELEMENT with multiple waves and repeated measurements, as this part of the data
is ok to present at this moment while all other part of the data are still confidential
outside the study team. I will specifically illustrate the whole process through a
specific project, which is mainly proposed to evaluate the effect of the environmental
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exposures such as prenatal and childhood lead exposure on adolescent's sexual
maturation.

3.1 Introduction to the Data Structure of ELEMENT Study
ELEMENT is comprised of three birth cohorts from Mexico City maternity hospitals
that have been successfully followed for over two decades. The study cohorts
(mother-infant pairs) were recruited from three maternity hospitals in Mexico City
that serve a low- to moderate-income population (Mexican Social Security Institute,
Manuel Gea Gonzalez Hospital, and National Institute of Perinatology). The initial
cohort began with the support from the Harvard Superfund Basic Research Program
and individual R01 grants and was an inter-institutional collaboration among
Harvard University, the Center for Population Health Research of the national
Institute of Public Health in Mexico, the American British Cowdray Medical Center
and the National Institute of Perinatology of Mexico, with approval from each study
location’s Institutional Review Board (IRB). With the movement of multiple
ELEMENT investigators from Harvard University to the University of Michigan
between 2006 and 2008, and from the University of Michigan to the University of
Toronto, the ELEMENT cohort has evolved into a collaboration among researchers
at University of Michigan, Harvard, and the University of Toronto with continued
interaction with all partner agencies in Mexico. At University of Michigan, School

26	
  

of Public Health (UM-SPH) data were extracted or newly collected from the existing
three birth cohorts.

The mother-child pairs of study participants were recruited over a series of years:
Cohort 1, 1994-1997; Cohort 2, 1997-2000; Cohort 3, 2001-2005. Data was
collected at various times throughout the prenatal period, early- to mid-childhood
and adolescence in Cohorts 1, 2, and 3, with significant overlap in data collected
during pregnancy, infancy and early childhood through age five (See Figure 1 on
Page 9). A fourth cohort began in 2007 under a similar study design. Some of the
information collected is common between cohorts and some differs slightly, as
measures have evolved over time for improved accuracy and precision. Table 1
below is a general compilation of data collected across the children’s life stages for
all ELEMENT cohorts, so specific variables may not be available in all subjects.
Since ELEMENT is an ongoing, longitudinal cohort, additional measures may be
added in future studies. Table 2 reflects data that has been collected from 1994
through 2014, which provides a rich source of secondary data potentially proposed
by the investigators.

All data collection for the ELEMENT studies occurs in Mexico, facilitated via
collaboration with the Instituto Nacional de Salud Publica (INSP) that has existed
since the longitudinal cohort was initiated in 1994. Study subjects include motherchild pairs who were originally recruited for ELEMENT participation before or duri-
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Table	
  1.	
  ELEMENT	
  Data	
  Collected	
  Across	
  Children’s	
  Life	
  Stages	
  for	
  Cohorts	
  1,	
  2,	
  and	
  3	
  
Study	
  Data	
  Collected	
  
Child’s	
  Lifestage	
  
Maternal	
  Measures	
  
Prenatal	
  

•
•
•
•
•

Perinatal	
  

Early	
  Childhood	
  
(0-‐5	
  years	
  old)	
  

Mid	
  

Childhood	
  

to	
  Adolescence	
  
(7-‐16	
  years	
  old)	
  

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

•
•
•

Child	
  Measures	
  

Socio-‐economic	
  status	
  (2	
  PL	
  
Urine	
  
Venous	
  blood	
  (2	
  PL	
  
Food	
  frequency	
  questionnaire	
  
(FFQ)	
  
Socio-‐economic	
  status	
  
questionnaire	
  
Socio-‐economic	
  status	
  
Patella	
  and	
  tibia	
  bone	
  lead	
  
Venous	
  blood	
  	
  
Urine	
  
Anthropometry	
  
Anthropometry	
  
FFQ	
  
Demographic	
  information	
  
Socio-‐economic	
  status	
  
Maternal	
  IQ	
  	
  
Screening	
  questionnaire	
  
Sociodemographic	
  questionnaire	
  
FFQ	
  
Lead/Metals	
  exposure	
  
questionnaire	
  
GPS	
  coordinates	
  
HOME	
  Inventory	
  
Blood	
  
Hair	
  
Nails	
  
Urine	
  
Anthropometry	
  (Height,	
  weight,	
  
waist,	
  chest,	
  arm,	
  and	
  calf	
  
circumferences)	
  
Blood	
  pressure	
  (simplified)	
  
Skinfold	
  thickness	
  
Psychometric	
  tests	
  (BASC-‐2,	
  
CADS,	
  BRIEF,	
  Structured	
  
Interview)	
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•
•
•
•
•
•
•
•
•
•

•
•
•
•
•
•

•
•
•
•
•
•

Birth	
  weight	
  
Birth	
  length	
  
Umbilical	
  cord	
  blood	
  
Bayley	
  Scales	
  of	
  Infant	
  Development	
  
II	
  (Spanish)	
  
Anthropometry	
  
Bayley	
  Scales	
  of	
  Infant	
  Development	
  
II	
  (Spanish)	
  
Mental	
  Development	
  Index	
  
McCarthy	
  Scales	
  
FFQ	
  
Anthropometry	
  (Height,	
  weight,	
  
waist,	
  chest,	
  arm,	
  and	
  calf	
  
circumferences)	
  
Blood	
  pressure	
  
Skinfold	
  thickness	
  
Bioelectrical	
  impedance	
  
Stage	
  of	
  sexual	
  maturation	
  
FFQ	
  
Psychometric	
  tests	
  (CANTAB,	
  
WRAVMA,	
  BASC,	
  CADS,	
  BRIEF,	
  WASI,	
  
Connors’,	
  Pre-‐Pulse	
  Inhibition)	
  
Blood	
  	
  
Hair	
  
Nails	
  
Urine	
  
DNA	
  (saliva)	
  
Accelerometry	
  data	
  	
  

ng pregnancy or shortly after giving birth, depending on the cohort. Current and
future studies based on this longitudinal cohort re-recruit mother child pairs to
explore related research study aims and continue to recruit new birth cohorts.
Primary data is collected in multiple locations in Mexico, depending on the specific
study requirements; these study locations include La Casita, the American British
Cowdray Medical Center, and the Instituto Nacional de Perinatologia (INPer).

Primary data for ELEMENT studies falls into three general categories: (1) data
collected via filling out the Study Visit Data Collection Form or study questionnaires
that is written on paper and directly entered into a database by the INSP Data Entry
Technician or practitioners at one of the clinical study locations, (2) data collected
from the visit that is directly entered by study practitioners into the computer via
secure form and (3) biological specimens that require analysis prior to generating
quantitative data that can be entered into a database. Examples of primary data that
are recorded on paper during the study visit include: socio-economic status,
demographic information, and responses to questionnaires. Data that is entered into a
computer form during the study visit includes anthropometric data. Biological
specimens may include urine, saliva, hair, nails, serum, and plasma. Multiple health
outcomes can be assessed from each of these biological specimens and analyses vary
by study.
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3.2 Our Plan for Data Harmonization and Data
Documentation

Figure 3. The flow chart of data collection, data entry, data management
and data analysis in ELEMENT study.

Figure 3 presents the flow chart of data collection, data entry, data management and
data analysis in the ELEMENT study. At the current stage, we have transferred all
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the raw data in a secure,	
   shared	
   computer	
   drive	
   internally	
   used	
   by	
   the	
   research	
   group	
  
members	
   with	
   authorization.	
   The	
   original	
   folder	
   was	
   created	
   for	
   the	
   multiple	
   founded	
  
projects	
   related	
   to	
   the	
   ELEMENT	
   cohort,	
   and	
   contains	
   the	
   most	
   comprehensive	
   historical	
  
data,	
  including	
  those	
  from	
  the	
  earliest	
  cohorts.	
  A	
  detailed	
  description	
  of	
  all	
  the	
  cohorts	
  can	
  
be	
  found	
  in	
  the	
  table	
  below:	
  
Table	
  2.	
  ELEMENT	
  Raw	
  Database	
  Collected	
  over	
  2000	
  subjects.	
  
Cohort	
  1	
  (1994-‐1997)	
  

Cohort	
  2	
  (1997-‐2000)	
  

Cohort	
  3	
  (2001-‐2005)	
  

C1	
  –	
  Cohort	
  1	
  

PL	
  –	
  Plasma	
  

SF	
  –	
  Super	
  Fund	
  

§
§
§
§

Followed	
  48	
  months	
  
Birth	
  cohort	
  
Mother	
  followed	
  12	
  months	
  
for	
  breast	
  feeding	
  study	
  
Proyecto	
  +	
  filio	
  

§
§
	
  

Followed	
  60	
  months	
  
Pregnancy	
  cohort	
  	
  

BI	
  –	
  Biomarker	
  
§
§
§

Followed	
  60	
  months	
  
Birth	
  cohort	
  
foliocc	
  

§
§

Followed	
  60	
  months	
  
Pregnancy	
  cohort	
  
	
  
	
  
	
  

	
  

Cholesterol	
  (2006~2007)	
  
Subjects	
  came	
  from	
  C1,	
  PL,	
  BI	
  and	
  SF	
  
	
  
P20	
  (2010,	
  n	
  =	
  250)	
  
§

Subjects	
  were	
  subset	
  of	
  Cholesterol	
  study	
  (i.e.,	
  PL+SF+BI)	
  
	
  
P01	
  (2015)	
  
§

§

New	
  data	
  collecting…	
  

For security considerations, the raw data can only be accessed by the specific data
manager assigned through the study team. All data are saved under a master Excel
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sheet, where each separate Excel sheet is used to save data related to recruitment,
surveys, and ultrasound data. Those files related to documentations, explanations,
and presentations are also saved here and can be accessed in the same way. At
DMMC, we have cleaned the data, unified the coding of common variables, created
understandable labels for each variable in the dataset, converted them to SAS data
files when needed, re-organized and restored the excel data files in the following
way according to functional variables. Figure 4 shows the newly reconstructed data
structure.

Figure 4. The new structure of our database with four modules
and available sets of functional variables stored in each module
for the ELEMENT study.
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This new data structure has four modules: Historical (1994-2005), Cholesterol
(2007), P20 (2010), and P01 (2015). Within each module, Figure 4 listed its subdatabases with specific functional meanings and documented the timing of
measurements within that module. This new data structure is easier for data
managers to locate the necessary variables of any newly proposed secondary data
analysis or scientific investigation. In more details, my work in the group
involved the following components:

•

Create and maintain a common database for human studies related to the
ELEMENT study cohorts

•

Develop standard code for common outcomes, unify coding for common
variables, create labels and unified format to harmonize the datasets

•

Develop SAS code for data cleaning, data merging, and data
reorganizations

•

Develop standard code for data validation for data quality control

•

Develop SAS codes to provide data statistics, and to perform simple data
analysis.

Below I will illustrate my work through a concrete example, where the goal is to
investigate how the prenatal and childhood environmental exposures such as lead
exposure affect adolescent's sexual maturation.
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3.3 A Case Study for Data Preparation Process: To investigate
how the environmental exposures such as prenatal and
childhood lead exposure affect adolescent's sexual
maturation.
3.3.1

Study goal

ELEMENT uses self-reported and physician-assessed Tanner Staging for genital
(boys), breast (girls), and pubic hair (both) development [40, 41] starting at
approximately 8 years of age. FF collects Tanner Staging via self-report from the
primary caregiver at age 9 and 15 years. COHRA children will have reached 8 years
of age by the end of the proposed follow-up period; thus, at this point in time, the
study plan to collect proxy-assisted Tanner Stage from the primary caregiver. By
leveraging all these data from three studies in an appropriate way, one can evaluate
how the prenatal and childhood environmental exposures such as lead exposure
affect adolescent's sexual maturation. Obviously, since the data are collected by
different study groups initially, and they have different formats and different
codings. One major job of DMMC will include some time-consuming but necessary
across cohort data harmonization and documentations. Since other data are
confidential, we will only present the work and results done with ELEMENT data.
Even within ELEMENT, as we described earlier, the data were collected during
different waves on different cohorts, and at different locations, data harmonization is
still a big challenge for further meta-analysis. The primary objective of data
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harmonization in ELEMENT is to understand inter-cohort commonalities and
heterogeneities, and to develop data harmonization and analytical approaches to
address key data discrepancy issues.

3.3.2

Fill in online request form

By filling out the online data request form, the following major information has been
provided by the study investigator, Dr. Peter Song, for the scientific investigation on
how adolescent's sexual maturation can be potentially affected by the prenatal and
childhood environmental exposures such as heavy metal exposures, lead exposures.
Project title: ELEMENT Sexual Maturation Study
Main Scientific Objective: How prenatal and childhood lead exposure affect
adolescent's sexual maturation
Principal Investigator: Peter Song
Specific Scientific Questions:
1. Is there an association between Mom's prenatal lead exposure with kid's
sexual maturation?
2. Is there a vulnerable window (like which trimester is more important)?
3. Is there a relationship between children's childhood lead exposure with
kid's sexual maturation?
Outcome (dependent variable): sexual maturation outcomes (self reported, or
physician diagnosed)
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Predictors (independent variables): all kinds of Mom's lead exposures, kid's lead
exposures, demographics.
Potential Confounders: kid's longitudinal measurements of health outcomes, age,
gender, race...

3.3.3

Data allocation in the database

After I received the data request form, I went through all details filled in the form,
and notice the main piont that this newly proposed secondary analysis is to
investigate how prenatal and childhood lead exposure affects adolescent’s sexual
maturation. Then I dig into the massive database and try to locate the information
that is related to express the levels each kid’s sexual maturation. In ELEMENT, the
sexual maturation inforamtion is collected for each kid through both self report
questionaires, and physician’s examination and scoring. For physician scoring, they
have a rigorous 4-page form to fill in, and all information is recorded in the data base
from each question in that form. Specifically, the following variables are of our
interest for the physician observed sexual maturation.

TN15_1: Physician observed pubic hair staging
TN15_2: Physician observed breast development (female only)
TN15_3: Physician observed genital development (male only)
TN15_4A: Physician observed testicle volume (male only), right
TN15_4B: Physician observed testicle volume (Male only), left
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For girls, the self report questionaire is as in Figure 5:

Figure 5. Self-reported questionaire for girls’ sexual maturation in ELEMENT.
The related variables that I locate in the database include the following:
F5:	
  Have	
  you	
  started	
  having	
  periods?	
  
F6:	
  If	
  yes,	
  at	
  what	
  age?	
  
F6B_AA:	
  First	
  period	
  (Year)	
  
F6B_MM:	
  First	
  period	
  (month)	
  
F6C_AA:	
  Last	
  period	
  (year)	
  
F6C_DD:	
  Last	
  period	
  (day)	
  
F6C_MM:	
  Last	
  period	
  (month)	
  
F9:	
   Please	
   choose	
   the	
   drawing	
   closest	
   to	
   your	
   stage	
   of	
   breast	
   development	
   by	
  
marking	
  your	
  answer	
  with	
  a	
  cross	
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F10:	
   Another	
   changes	
   is	
   the	
   growth	
   of	
   pubic	
   hair.	
   	
   Please	
   choose	
   the	
   drawing	
  
closest	
  to	
  your	
  stage	
  of	
  hair	
  development	
  by	
  marking	
  your	
  answer	
  with	
  a	
  cross	
  

The self-reported questionaire for boys is as in Figure 6,

Figure 6. Self-reported questionaire for boys’ sexual maturation in ELEMENT.

and the related variables that I locate in the database include the following:

M7:	
  Your	
  stage	
  of	
  penis	
  and	
  scrotum	
  development	
  
M8:	
  Your	
  stage	
  of	
  pubic	
  hair	
  development	
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Similar data information related to sexual maturation is saved within P20(2010)
module separately in three different datasets (P20_Adolescent_Maturation_F.csv,
P20_Adolescent_Maturation_M.csv, P20_Adolescent_Maturation_P.csv), as well as
within P01(2015) module in one big dataset (P01_Adolescent_Maturation.csv with
totally different variable names), and within Cholesterol(2007) module in one dataset
but with simpler questionaire designed at that time and thus less data information
collected (Cholesterol_Adolescent_Maturation.csv with only similar questions to F9,
F10, M7, M8 listed above).
Obviously, the main predictors for this project will need to include all longitudianl
measurements of both Mom’s prenatal lead exposures and kid’s lead exposures in
their early lives. These exposure measurements are all saved in the Historical(19942005) module. Specifically, we located two databases related to lead exposure
records and extracted them into two data files: “Historical_Child_Blood_Lead.csv”
and “Historical_Mom_Blood_Lead.csv”, with much simpler data structure. One
contains child blood lead level from month 1 to 60, and the other contains mom
blood bead level from trimester 1 to time when child is 12 month of age. Besides, we
also need to include other covariates in the database such as demographics( age,
race, gender, weight, height, and BMI), and some other potential confounders, for
instance, kid’s longitudinal measurements of health outcomes, Mom’s age of at
delivery, smoking status of Mother, etc. Such information can be found in all four
data modules: Historical (1994-2005), Cholesterol (2007), P20 (2010), and P01
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(2015). The specific 4 datasets related to demographics and other health outcome
records

of

either

kid

or

mom

are:

“Historical_Mom_General_Info.csv”,

“Cholesterl_Adolescent_Anthro.csv”,
“P20_Adlescen_Anthro.csv”

and

“P01_Adlescen_Anthro.csv”.

3.3.4

Data harmonization and documentation

As we described in the previous session, the data saved in different modules may
have different formats or different variable names, since they were collected during
different time periods of the ELEMENT studies. Over the time as the design of the
study gets improved, some new information is collected while it was not at an earlier
stage or wave of cohorts. To achieve data harmonization, we (1) created overall data
dictionaries of the existing data to transfer knowledge of the entire data availability
to all investigators; (2) tried to understand commonalities and heterogeneities across
different longitudinal study cohorts of ELEMENT, with respect to study design, data
collection procedure, study population, measurements and cohesiveness of data
sources across different cohort studies, and (3) identify any missing data, and
examine the consistency, availability and variability of variables measured across
different study cohorts, and develop data harmonization approaches to addressing
key data discrepancy issues. After all these cleaning and harmonization work, I read
in the corresponding files about the 11 datasets mentioned in Section 3.3.3 in SAS,
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with unified data format, data structure, variable names, variable labels, and etc.
According to the submitted data request, I selected 88 related variables to keep in the
newly created datasets including kid’s sexual maturation outcomes, Mom’s lead
exposures, kid’s lead exposures, demographics of both mom and kid, and other
potential confounders. Then I sort each dataset by ID and type of cohort. With this
sorting, finally, I managed to merge those datasets according to ID and cohort type
in one data file to deliver. The SAS code for data cleaning, data harmonization and
data merging can be found in the appendix. Below is the output from SAS about the
contents of our final data file.
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Chapter 4. Descriptive Statistics and Data Quality Control

4.1 Basic Statistical Tools in SAS for Descriptive Statistics
and Detecting Potential Outliers
Descriptive statistics provide simple summaries about the study cohort and the
various measures collected in the dataset, which are typically employed by data
manager to quickly take a snapshot of the data in a study, describe the basic features
of the dataset prepared, and help detect some potential data errors, such as entry
typos, missing values, outliers by mistakes. Together with simple graphics analysis,
they form the basis of virtually every quantitative analysis of data. [42, 43]
For each univariate variable, descriptive analysis involves describing the distribution
of a single variable (including the mean, median, range, variance and standard
deviation). Characteristics of a variable's distribution may also be depicted in
graphical or tabular format, including histograms, box-plot and stem-and-leaf
display. With bivariate or multivariate analysis, descriptive statistics may be used to
describe the relationship between pairs of variables. In this case, some descriptive
statistics that can be used are: scatterplots, quantitative measures of dependence,
spaghetti plot for longitudinal trajectory, and etc. Bivariate analysis can also be used
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to describe the relationship between the dependent variable and the predictors. The
slope in regression analysis, for example, can reflect the relationship between
variables. Descriptive analysis can also help examine the skewness of data
distribution and help justify whether certain transformation such as log
transformation is necessary for each variable. Use of log transformation makes data
distribution more symmetrical and look more similar to the normal distribution,
making them easier to interpret intuitively. More complicated statistical methods can
be found in the literature to validate the data integration procedure when performing
formal statistical inferences for merged data. [44-47]

4.2 Example of Data Quality Control when Preparing Data
for investigating how the environmental exposures such as
prenatal and childhood lead exposure affect adolescent's
sexual maturation.
We first examined every univariate to detect some potential problems, such as
missing values, potential outliers due to entry mistakes, whether range, median
makes sense, etc. Then we compared sub-cohorts between different sexual
maturation level groups. The following tables summarize the maternal characteristics
and children’s characteristics stratified by self-reported sexual maturation stages and
physician judged sexual maturation levels.
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Table 3: Descriptive Statistics of maternal characteristics and children’s
characteristics stratified by girl’s self-reported stage of breast development
Characteristics

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

26 (8)

26 (5)

27 (9)

23.5 (6)

24 (5)

Pre-pregnancy BMI (median,
IQR)

26.19 (8.41)

28.79 (4.95)

22.33 (1.97)

25.97 (3.22)

24.56 (.84)

Total months of
breastfeeding (median, IQR)

8 (9)

6 (9)

7 (9)

10 (11.5)

7 (15)

Yes

56 (47.86%)

56 (45.16%)

47 (45.19%)

20 (33.9%)

18 (47.37%)

No

61 (52.14%)

68 (54.84)

57 (54.81%)

39 (66.1%)

20 (52.63%)

Yes

4 (3.42%)

5 (4%)

8 (7.55%)

3 (5%)

2 (5.26%)

No

113 (96.58%)

120 (96%)

98 (92.45%)

57 (95%)

36 (94.74%)

Birth weight (median, IQR)

3 (0)

3 (0)

3 (0)

3 (0)

3 (0)

Birth length (median, IQR)

50 (2)

50 (3)

50 (2)

50 (4)

48.5 (3)

Head circumference
(median, IQR)

34 (2)

34 (2)

34 (2)

34 (2)

33 (2)

Blood pressure (diastolic)
(median, IQR)

63 (10)

68 (9)

71 (5)

68 (18)

68 (0)

Blood pressure (systolic)
(median, IQR)

99 (15)

106 (19)

109 (12)

107 (29)

99 (0)

16.99 (3.63)

18.98 (4.74)

21.41 (4.71)

22.7 (4.45)

21.60 (4.15)

Maternal
Age (median, IQR)

History of smoking

Smoking during pregnancy

Child

BMI (median, IQR)

Stage 1: The nipple is raised a little. The rest of the breast is still flat.
Stage 2: The breast is a little larger and the nipple is raised a little more. The darker-colored area around the nipple
(areola) is a little bit bigger than is State 1. Sometimes you can feel a small lump inside the nipples.
Stage 3: The darker-colored area around the nipple (areola) and the breast are much larger than in Stage 2 and
form a mound. The areola does not stick cut away from the breast.
Stage 4: The nipple and the areola stick out away from the skin and the rest of the breast.
Stage 5: The nipple sticks out away from the skin and the rest of the breast. The areola is at the same level than the
rest of the breast
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Table 4: Descriptive Statistics of maternal characteristics and children’s
characteristics stratified by girl’s self-reported stage of pubic hair development
Characteristics

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

Age (median, IQR)

26 (7)

26 (5)

25 (7)

22 (7)

22 (2)

Pre-pregnancy BMI
(median, IQR)

30.18 (9.49)

24.26 (0)

25.21 (2)

25.30 (.02)

24.56 (0)

7 (9)

7 (9)

6 (9)

7 (10)

5 (10)

Yes

83 (47.98%)

42 (42.42%)

39 (37.5%)

29 (48.33%)

4 (66.67%)

No

90 (52.02%)

57 (57.28%)

65 (62.5%)

31 (51.67%)

2 (33.33%)

Yes

10 (5.78%)

1 (1.04%)

4 (3.7%)

7 (11.11%)

0 (0%)

No

163 (94.22%)

95 (98.96%)

104 (96.3%)

56 (88.89%)

6 (100%)

Birth weight (median,
IQR)

3 (0)

3 (0)

3 (0)

3 (0)

3 (0)

Birth length (median, IQR)

50 (2)

49.5 (3)

50 (3)

50 (3)

48 (3)

Head circumference
(median, IQR)

34 (2)

34 (2)

34 (2)

34 (1)

33 (3)

Blood pressure (diastolic)
(median, IQR)

65 (9)

69 (9)

71 (4)

71 (1)

n/a

Blood pressure (systolic)
(median, IQR)

100 (18)

99 (18)

110 (16)

111 (3)

n/a

17.81 (4.28)

19.30 (6.17)

21.4 (4.36)

21.82 (4.01)

21.39 (5.07)

Maternal

Total months of
breastfeeding (median,
IQR)
History of smoking

Smoking during
pregnancy

Child

BMI (median, IQR)

Stage 1: There is no pubic hair.
Stage 2: There is a little, long, lightly colored hair. This hair may be straight or a little curly.
Stage 3: The hair is a little darker, coarse, and more curled. It has spread out and covers almost all the pubic area.
Stage 4: The hair is now as dark, curly, and coarse as that of a grown woman. The hair covers all the pubic area
but does not spread out to the thighs.
Stage 5: The hair is like that of a grown woman (dark, curly, and coarse). The hair forms a triangle covering all the
pubic area, and has spread out to the inner thighs.

46	
  

Table 5: Descriptive Statistics of maternal characteristics and children’s
characteristics stratified by boy’s self-reported stage of penis and scrotum
development
Characteristics

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

Age (median, IQR)

25 (7)

23 (6)

26 (7)

26 (7)

24 (13)

Pre-pregnancy BMI
(median, IQR)

21.71 (7.14)

23.95 (2.69)

33.26 (7.82)

26.94 (6.81)

23.80 (13.48)

6 (6)

7 (9)

6 (8)

7 (8)

11 (9)

Yes

26 (45.61%)

72 (44.44%)

43 (35.83%)

46 (50%)

6 (35.29%)

No

31 (54.39%)

90 (55.56%)

77 (64.17%)

46 (50%)

11 (64.71%)

Yes

n/a

7 (4.22%)

43 (35.83%)

3 (3.13%)

n/a

No

57 (100%)

159 (95.78%)

77 (64.17%)

93 (96.88%)

17 (100%)

Birth weight (median,
IQR)

3 (0)

3 (1)

3 (1)

3 (1)

3 (0)

Birth length (median, IQR)

50 (3)

50 (3)

50 (3)

51 (2)

50 (2)

Head circumference
(median, IQR)

34 (1)

35 (1)

34 (2)

35 (2)

33 (2.5)

Blood pressure (diastolic)
(median, IQR)

71 (13)

62 (9)

68.5 (9)

70 (4)

70 (9)

Blood pressure (systolic)
(median, IQR)

99 (18)

102 (16)

107 (12.5)

108.5 (11)

111 (11)

16.36 (5.27)

18.39 (4.92)

20.71 (6.17)

17.97 (6.94)

19.81 (4.86)

Maternal

Total months of
breastfeeding (median,
IQR)
History of smoking

Smoking during
pregnancy

Child

BMI (median, IQR)

Stage 1: The scrotum and penis are the same size as when you were younger.
Stage 2: The scrotum has lowered a bit and the penis is a little larger.
Stage 3: The penis is much longer and the scrotum much larger.
Stage 4: The penis is longer and wider. The scrotum is darker and larger than before.
Stage 5: The penis and scrotum are the size and shape of an adult.
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Table 6: Descriptive Statistics of maternal characteristics and children’s
characteristics stratified by boy’s self-reported stage of pubic hair development
Characteristics

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

Age (median, IQR)

25 (7)

26 (8)

26 (7)

25.5 (4)

26 (8)

Pre-pregnancy BMI
(median, IQR)

25.05 (5.22)

22.47 (3)

23.8 (2.96)

26.06 (9.02)

n/a

7 (8)

7 (8)

7 (11)

6 (9)

5.5 (5)

Yes

90 (41.86%)

42 (47.19%)

27 (43.55%)

26 (40.63%)

8 (44.44%)

No

125 (58.14%)

47 (52.81%)

35 (56.45%)

38 (59.38%)

10 (55.56%)

Yes

2 (.93%)

9 (9.47%)

1 (1.49%)

2 (3.03%)

n/a

No

213 (99.07%)

86 (90.53%)

66 (98.51%)

64 (96.97%)

18 (100%)

Birth weight (median,
IQR)

3 (1)

3 (0)

3 (1)

3 (0)

3 (0)

Birth length (median,
IQR)

50 (3)

50 (3)

51 (2)

50 (3)

51 (2)

Head circumference
(median, IQR)

34 (2)

34.5 (1)

34 (2)

35 (2)

35 (2)

Blood pressure
(diastolic) (median, IQR)

63 (9)

70 (7)

70 (1)

71 (0)

70 (0)

Blood pressure (systolic)
(median, IQR)

100 (16)

111 (7)

110 (3)

109 (3)

119 (0)

18.24 (4.93)

19.9 (6.1)

21.48 (6.92)

20.77 (7.96)

22.45 (4)

Maternal

Total months of
breastfeeding (median,
IQR)
History of smoking

Smoking during
pregnancy

Child

BMI (median, IQR)

Stage 1: There is no pubic hair.
Stage 2: There is a little, long, lightly colored hair. This hair may be straight or a little curly.
Stage 3: The hair is a little darker, coarse, and more curled. It has spread out and covers almost all the pubic area.
Stage 4: The hair is now as dark, curly, and coarse as that of a grown woman. The hair covers all the pubic area
but does not spread out to the thighs.
Stage 5: The hair is like that of a grown woman (dark, curly, and coarse). The hair forms a triangle covering all the
pubic area, and has spread out to the inner thighs.
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No obvious outlier has been detected from all sub-group descriptive analysis.
However, we noticed that maternal BMI is missing for stage 5 group from Table 6,
while all other variables still have values falling into reasonable range. Need to look
at the data and see what is going on and whether it is a real missing value.
Notice we have repeated measurements of child blood lead exposure and mom’s
blood lead exposure. To capture the change over time, we plotted the boxplot
trajectory of these two variables across different time in months (Figures 5 and 6).

Figure 7. Boxplot of Child Blood Lead Over Time, with child’s birth
as the reference time.
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Figure 8. Boxplot of Mom Blood Lead Over Time, with child’s birth as
the reference time.
Both variables fluctuated over time, which indicated that both mom’s prenatal lead
exposure and children’s early childhood lead exposure in our study vary as time goes
on. This could be due to seasonal effect or food, diet, and nutrition effect. Over time,
the variation of the measurement does not change much. To see how the lead
exposure is related to kid’s sexual maturation, we further examined the spaghetti
plots of lead exposure over time stratified by sexual maturation stages (Figures 7 and
8). As one can see from the figures, across different sexual maturation groups, the
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mother’s blood lead exposure level do differ from one another, so as the child blood
lead levels, which is relative higher for less sexually matured kids.

Figure 9. Spaghetti plot of mom blood lead exposure trajectory over time,
stratified by different measurements of sexual maturation stages.
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Figure 10. Spaghetti plot of child blood lead exposure trajectory over time, stratified
by different measurements of sexual maturation stages.
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Chapter 5. Summary
Data management and data facilitation is the foundation and a critical part for
scientific investigations, especially with large cohort studies on health care, which
may have multiple components collected from different institutes or different areas
due to efficiency, cost, enrollment considerations. In this thesis, we have presented
how we designed and implemented data management with a multi-center health care
research project, ECHO (Environmental Influences on Child Health Outcomes). This
research project is mainly focusing on environmental health sciences, and the
primary goal is to investigate the impact of nutritional and toxicant exposures in
environment during fetal and early postnatal life on individual’s health outcomes
over the life course. More specifically, I illustrated my work through an example
project in ELEMENT study for investigating how the prenatal and childhood
environmental exposures such as lead exposure affect adolescent's sexual
maturation. I have presented my work on designing the data management plan and
program codes for the data management and modeling core, facilitating and
accomplishing data communication, cleaning and unifying data labels and formats,
preparing datasets to achieve desirable data structures for further statistical analysis,
and controlling data quality to ensure the overall research quality.
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The study cohorts we considered also have another challenge, i.e. they all include
repeated measures of social and/or chemical exposure through sensitive
developmental periods. Approaches to disentangle whether there is variation in
susceptibility due to timing of exposure are thus needed. In addition to using
regression models as we presented where exposures measured during a given time
period are fitted in separate models (one model for each time period of exposure),
some novel approaches can be applied to consider the entire pattern of exposure
through the life course as a predictor of the outcome [48, 49]. These methods have
been used to identify windows of vulnerability to environmental toxicants [49], and
have been extended to quantify the joint (interactive) effects of two factors (e.g.,
considering chemical exposures and social factors together). It is definitely of great
future research interest, but is beyond the scope of this thesis.
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SAS code Appendix:
/**************************************** PART I read the seven csv files AND MERGE
**********************************/
/*DATA 1.1*/
DATA DATA1_1;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\Cholesterol(2007)\Cholesterol_Adolescent_Anthro.csv" DSD FIRSTOBS=2;
INPUT FAKEID PROYECTO $ ETAPACC $ SEX_CH WEIGHT_CH HEIGHT_CH AGE X_AGEMONS
X_CBMI X_ZBFA;
RUN;
PROC PRINT DATA=DATA1_1;
RUN;
/*DATA 1.2*/
DATA DATA1_2;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\Cholesterol(2007)\Cholesterol_Adolescent_Maturation.csv" DSD FIRSTOBS=2;
INPUT FAKEID PROYECTO $ ETAPACC $ F9 F10 M7 M8;
RUN;
PROC PRINT DATA=DATA1_2;
RUN;
/*DATA 2.1*/
DATA DATA2_1;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\Historical(1994-2005)\Historical_Child_Blood_Lead.csv" DLM='2C0D'X DSD MISSOVER
LRECL=10000 FIRSTOBS=2;
INPUT FAKEID PROYECTO $ PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24 PB_C_30
PB_C_36 PB_C_42 PB_C_48 PB_C_60;
RUN;
PROC PRINT DATA=DATA2_1;
RUN;
/*DATA 2.2*/
DATA DATA2_2;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\Historical(1994-2005)\Historical_Mom_Blood_Lead.csv" DLM='2C0D'X DSD MISSOVER
LRECL=10000 FIRSTOBS=2;
INPUT FAKEID PROYECTO $ PB_M_11 PB_M_12 PB_M_13 PB_CORD PB_M_20 PB_M_21
PB_M_23 PB_M_24 PB_M_27 PB_M_212 ;
RUN;
PROC PRINT DATA=DATA2_2;
RUN;
/*DATA 2.3*/
DATA DATA2_3;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\Historical(1994-2005)\Historical_Mom_General_Info.csv" DLM='2C0D'X DSD MISSOVER
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LRECL=10000 FIRSTOBS=2;
INPUT FAKEID PROYECTO $ AGE_M BIRTHDATE_M $ MARITAL_STATUS WRITE_READ
SCHOOL_T1 SCHOOLP_T DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC
DELIVERY_GESTAGE DELIVERY_MULTIPLE
DELIVERY_TYPE DELIVERY_SEX DELIVERY_APGAR1MIN DELIVERY_APGAR5MIN
DELIVERY_PBCORD ROTULA_QUALITYCHECK TIBIA_QUALITYCHECK HRP_PARITY SMHX SMNOW_1MOPP
CIGSDAY_1MOPP SMPREG CIGSDAYPREG PREPREGNANCYBMI
MONTHS_SINCE_QUIT_SMK CALCIUM_TRT BF_TOTAL_1STRECALL FECHANAC $;
RUN;
PROC PRINT DATA=DATA2_3;
RUN;
/*DATA 4.1*/
DATA DATA4_1;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\P20(2010)\P20_Adolescent_Anthro.csv" DLM='2C0D'X DSD MISSOVER LRECL=10000
FIRSTOBS=2;
INPUT FAKEID PROYECTO $ SEXO_H CD_AGE WEIGHT HEIGHT WAIST TRI_SKIN SUP_SKIN
SUB_SKIN PR_DIAS PR_SIS X_AGEMONS X_CBMI X_ZBFA;
RUN;
PROC PRINT DATA=DATA4_1;
RUN;

/*DATA 4.2*/
DATA DATA4_2;
INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis
Data\P20(2010)\P20_Adolescent_Maturation.csv" DLM='2C0D'X DSD MISSOVER LRECL=10000
FIRSTOBS=2;
INPUT FAKEID PROYECTO $ SEXO_H F5 F6 F6B_AA F6B_MM F6C_AA F6C_DD F6C_MM F9
F10 M7 M8 TN13 TN14 TN15_1 TN15_2 TN15_3 TN15_4A TN15_4B;
RUN;
PROC PRINT DATA=DATA4_2;
RUN;
/*SORT AND MERGE THE DATA1*/
PROC SORT DATA=DATA1_1 OUT=DATA11;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA1_2 OUT=DATA12;
BY FAKEID PROYECTO;
RUN;
DATA DATA1;
MERGE DATA11 DATA12;
BY FAKEID PROYECTO;
RUN;
PROC PRINT DATA=DATA1;
RUN;
/*SORT AND MERGE THE DATA2*/
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PROC SORT DATA=DATA2_1 OUT=DATA21;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA2_2 OUT=DATA22;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA2_3 OUT=DATA23;
BY FAKEID PROYECTO;
RUN;
DATA DATA2;
MERGE DATA21 DATA22 DATA23;
BY FAKEID PROYECTO;
RUN;
PROC PRINT DATA=DATA2;
RUN;
/*SORT AND MERGE THE DATA4*/
PROC SORT DATA=DATA4_1 OUT=DATA41;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA4_2 OUT=DATA42;
BY FAKEID PROYECTO;
RUN;
DATA DATA4;
MERGE DATA41 DATA42;
BY FAKEID PROYECTO;
RUN;
PROC PRINT DATA=DATA4;
RUN;
/*SORT AND MERGE THE DATA*/
PROC SORT DATA=DATA1 OUT=DATANEW1;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA2 OUT=DATANEW2;
BY FAKEID PROYECTO;
RUN;
PROC SORT DATA=DATA4 OUT=DATANEW4;
BY FAKEID PROYECTO;
RUN;
DATA DATA;
MERGE DATANEW1 DATANEW2 DATANEW4;
BY FAKEID PROYECTO;
RUN;
PROC PRINT DATA=DATA;
RUN;
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/************************************************************ PART II TIME PLOT
*************************************************/
/*DESCRIPTION OF DATA*/
PROC CONTENTS DATA=DATA;
RUN;
/* CATEGORY OF RESPONSE*/
PROC FREQ DATA=DATA;
TABLES F9 F10 M7 M8;
RUN;
/*CHILD BLOOD LEAD*/
DATA NEWDATA1;
SET DATA;
KEEP FAKEID SEX_CH F9 F10 M7 M8 PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24
PB_C_30 PB_C_36 PB_C_42 PB_C_48 PB_C_60 ;
RUN;
DATA NEWDATAC2;
SET NEWDATA1;
IF F9=1 THEN GROUP1="F9_1";
IF F9=2 THEN GROUP1="F9_2";
IF F9=3 THEN GROUP1="F9_3";
IF F9=4 THEN GROUP1="F9_4";
IF F9=5 THEN GROUP1="F9_5";
IF F10=1 THEN GROUP2="F10_1";
IF F10=2 THEN GROUP2="F10_2";
IF F10=3 THEN GROUP2="F10_3";
IF F10=4 THEN GROUP2="F10_4";
IF F10=5 THEN GROUP2="F10_5";
IF M7=1 THEN GROUP3="M7_1";
IF M7=2 THEN GROUP3="M7_2";
IF M7=3 THEN GROUP3="M7_3";
IF M7=4 THEN GROUP3="M7_4";
IF M7=5 THEN GROUP3="M7_5";
IF M8=1 THEN GROUP4="M8_1";
IF M8=2 THEN GROUP4="M8_2";
IF M8=3 THEN GROUP4="M8_3";
IF M8=4 THEN GROUP4="M8_4";
IF M8=5 THEN GROUP4="M8_5";
Y=PB_C_1; TIME=1; OUTPUT;
Y=PB_C_3; TIME=3; OUTPUT;
Y=PB_C_6; TIME=6; OUTPUT;
Y=PB_C_12; TIME=12; OUTPUT;
Y=PB_C_18; TIME=18; OUTPUT;
Y=PB_C_24; TIME=24; OUTPUT;
Y=PB_C_30; TIME=30; OUTPUT;
Y=PB_C_36; TIME=36; OUTPUT;
Y=PB_C_42; TIME=42; OUTPUT;
Y=PB_C_48; TIME=48; OUTPUT;
Y=PB_C_60; TIME=60; OUTPUT;
DROP F9 F10 M7 M8 PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24 PB_C_30
PB_C_36 PB_C_42 PB_C_48 PB_C_60;
RUN;
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PROC PRINT DATA=NEWDATAC2;
RUN;
/*F9 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAC2G1;
SET NEWDATAC2(WHERE=(Y NE .));
RUN;
DATA NEWDATAC2G1;
SET NEWDATAC2G1(WHERE=(GROUP1 NE ""));
RUN;
PROC SORT DATA=NEWDATAC2G1;
BY GROUP1 TIME;
RUN;
PROC MEANS DATA=NEWDATAC2G1;
VAR Y;
BY GROUP1 TIME;
OUTPUT OUT=NEWDATAC2G1_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAC2G1_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP1/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 1 FOR CHILD BLOOD LEAD LEVEL (FEMALE)";
RUN;
/*F10 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAC2G2;
SET NEWDATAC2(WHERE=(Y NE .));
RUN;
DATA NEWDATAC2G2;
SET NEWDATAC2G2(WHERE=(GROUP2 NE ""));
RUN;
PROC SORT DATA=NEWDATAC2G2;
BY GROUP2 TIME;
RUN;
PROC MEANS DATA=NEWDATAC2G2;
VAR Y;
BY GROUP2 TIME;
OUTPUT OUT=NEWDATAC2G2_MEAN1 MEAN=MEANY;
RUN;
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SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAC2G2_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP2/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 2 FOR CHILD BLOOD LEAD LEVEL (FEMALE)";
RUN;
/*M7 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAC2G3;
SET NEWDATAC2(WHERE=(Y NE .));
RUN;
PROC PRINT DATA=NEWDATAC2G3;
RUN;
DATA NEWDATAC2G3;
SET NEWDATAC2G3(WHERE=(GROUP3 NE ""));
RUN;
PROC SORT DATA=NEWDATAC2G3;
BY GROUP3 TIME;
RUN;
PROC MEANS DATA=NEWDATAC2G3;
VAR Y;
BY GROUP3 TIME;
OUTPUT OUT=NEWDATAC2G3_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAC2G3_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP3/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 3 FOR CHILD BLOOD LEAD LEVEL (MALE)";
RUN;
/*M8 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAC2G4;
SET NEWDATAC2(WHERE=(Y NE .));
RUN;
PROC PRINT DATA=NEWDATAC2G4;
RUN;

67	
  

DATA NEWDATAC2G4;
SET NEWDATAC2G4(WHERE=(GROUP4 NE ""));
RUN;
PROC SORT DATA=NEWDATAC2G4;
BY GROUP4 TIME;
RUN;
PROC MEANS DATA=NEWDATAC2G4;
VAR Y;
BY GROUP4 TIME;
OUTPUT OUT=NEWDATAC2G4_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAC2G4_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP4/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 4 FOR CHILD BLOOD LEAD LEVEL (MALE)";
RUN;

/*MOTHER BLOOD LEAD*/
DATA NEWDATA1_1;
SET DATA;
KEEP FAKEID SEX_CH F9 F10 M7 M8 PB_M_11 PB_M_12 PB_M_13 PB_M_20 PB_M_21
PB_M_23 PB_M_24 PB_M_27 PB_M_212;
RUN;
DATA NEWDATAM2;
SET NEWDATA1_1;
IF F9=1 THEN GROUP1="F9_1";
IF F9=2 THEN GROUP1="F9_2";
IF F9=3 THEN GROUP1="F9_3";
IF F9=4 THEN GROUP1="F9_4";
IF F9=5 THEN GROUP1="F9_5";
IF F10=1 THEN GROUP2="F10_1";
IF F10=2 THEN GROUP2="F10_2";
IF F10=3 THEN GROUP2="F10_3";
IF F10=4 THEN GROUP2="F10_4";
IF F10=5 THEN GROUP2="F10_5";
IF M7=1 THEN GROUP3="M7_1";
IF M7=2 THEN GROUP3="M7_2";
IF M7=3 THEN GROUP3="M7_3";
IF M7=4 THEN GROUP3="M7_4";
IF M7=5 THEN GROUP3="M7_5";
IF M8=1 THEN GROUP4="M8_1";
IF M8=2 THEN GROUP4="M8_2";
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IF M8=3 THEN GROUP4="M8_3";
IF M8=4 THEN GROUP4="M8_4";
IF M8=5 THEN GROUP4="M8_5";
Y=PB_M_11; TIME=-3; OUTPUT;
Y=PB_M_12; TIME=-2; OUTPUT;
Y=PB_M_13; TIME=-1; OUTPUT;
Y=PB_M_20; TIME=0; OUTPUT;
Y=PB_M_21; TIME=1; OUTPUT;
Y=PB_M_23; TIME=3; OUTPUT;
Y=PB_M_24; TIME=4; OUTPUT;
Y=PB_M_27; TIME=7; OUTPUT;
Y=PB_M_212; TIME=12; OUTPUT;
DROP F9 F10 M7 M8 PB_M_11 PB_M_12 PB_M_13 PB_M_20 PB_M_21 PB_M_23 PB_M_24
PB_M_27 PB_M_212;
RUN;
PROC PRINT DATA=NEWDATAM2;
RUN;
/*F9 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAM2G1;
SET NEWDATAM2(WHERE=(Y NE .));
RUN;
DATA NEWDATAM2G1;
SET NEWDATAM2G1(WHERE=(GROUP1 NE ""));
RUN;
PROC SORT DATA=NEWDATAM2G1;
BY GROUP1 TIME;
RUN;
PROC MEANS DATA=NEWDATAM2G1;
VAR Y;
BY GROUP1 TIME;
OUTPUT OUT=NEWDATAM2G1_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAM2G1_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP1/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 1 FOR MOTHER BLOOD LEAD LEVEL (FEMALE)";
RUN;
/*F10 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAM2G2;
SET NEWDATAM2(WHERE=(Y NE .));
RUN;
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DATA NEWDATAM2G2;
SET NEWDATAM2G2(WHERE=(GROUP2 NE ""));
RUN;
PROC SORT DATA=NEWDATAM2G2;
BY GROUP2 TIME;
RUN;
PROC MEANS DATA=NEWDATAM2G2;
VAR Y;
BY GROUP2 TIME;
OUTPUT OUT=NEWDATAM2G2_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAM2G2_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "MONTH BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP2/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 2 FOR MOTHER BLOOD LEAD LEVEL (FEMALE)";
RUN;
/*M7 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAM2G3;
SET NEWDATAM2(WHERE=(Y NE .));
RUN;
PROC PRINT DATA=NEWDATAM2G3;
RUN;
DATA NEWDATAM2G3;
SET NEWDATAM2G3(WHERE=(GROUP3 NE ""));
RUN;
PROC SORT DATA=NEWDATAM2G3;
BY GROUP3 TIME;
RUN;
PROC MEANS DATA=NEWDATAM2G3;
VAR Y;
BY GROUP3 TIME;
OUTPUT OUT=NEWDATAM2G3_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;
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PROC GPLOT DATA=NEWDATAM2G3_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP3/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 3 FOR MOTHER BLOOD LEAD LEVEL (MALE)";
RUN;
/*M8 GROUP MEAN RESPONSE TIME PLOT*/
DATA NEWDATAM2G4;
SET NEWDATAM2(WHERE=(Y NE .));
RUN;
PROC PRINT DATA=NEWDATAM2G4;
RUN;
DATA NEWDATAM2G4;
SET NEWDATAM2G4(WHERE=(GROUP4 NE ""));
RUN;
PROC SORT DATA=NEWDATAM2G4;
BY GROUP4 TIME;
RUN;
PROC MEANS DATA=NEWDATAM2G4;
VAR Y;
BY GROUP4 TIME;
OUTPUT OUT=NEWDATAM2G4_MEAN1 MEAN=MEANY;
RUN;
SYMBOL1
SYMBOL2
SYMBOL3
SYMBOL4
SYMBOL5

INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN
INTERPOL=JOIN

VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2;
VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2;
VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2;
VALUE=HASHFILLED COLOR=VIP HEIGHT=2;
VALUE=STARFILLED COLOR=VIOY HEIGHT=2;

PROC GPLOT DATA=NEWDATAM2G4_MEAN1;
AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)");
AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL");
PLOT MEANY*TIME=GROUP4/HAXIS=AXIS1 VAXIS=AXIS2;
TITLE "TIME PLOT 4 FOR MOTHER BLOOD LEAD LEVEL (MALE)";
RUN;

/************************************************************ PART III BOXPLOT
*************************************************/
/* BOXPLOT FOR CHILD BLOOD BY TIME*/
SYMBOL VALUE=DOT HEIGHT=.4 INTERPOL=BOXTF WIDTH=3 BWIDTH=5 COLOR=BLACK CV=TAN;
AXIS1 ORDER=(0 TO 45 BY 10) LABEL=(HEIGHT=1.25 ANGLE=90 'CHILD BLOOD LEAD')
MINOR=(NUMBER=1);
AXIS2

LABEL=(HEIGHT=1.25 'TIME (MONTHS)') OFFSET=(5,5);

PROC GPLOT DATA=NEWDATAC2 UNIFORM;
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PLOT Y*TIME /HAXIS=AXIS2 VAXIS=AXIS1 HMINOR=0 SKIPMISS;
TITLE "BOXPLOT FOR CHILD BLOOD LEAD OVER TIME";
RUN;
/* BOXPLOT FOR MOTHER BLOOD BY TIME*/
SYMBOL VALUE=DOT HEIGHT=.4 INTERPOL=BOXTF WIDTH=3 BWIDTH=5 COLOR=BLACK CV=TAN;
AXIS1 ORDER=(0 TO 45 BY 10) LABEL=(HEIGHT=1.25 ANGLE=90 'MOTHER BLOOD LEAD')
MINOR=(NUMBER=1);
AXIS2

LABEL=(HEIGHT=1.25 'TIME (MONTHS)') OFFSET=(5,5);

PROC GPLOT DATA=NEWDATAM2 UNIFORM;
PLOT Y*TIME /HAXIS=AXIS2 VAXIS=AXIS1 HMINOR=0 SKIPMISS;
TITLE "BOXPLOT FOR MOTHER BLOOD LEAD OVER TIME";
RUN;
/************************************************************ PART IV
CHARACTERISTICS *************************************************/
/*TABLE FOR F9*/
/*F91*/
DATA F91;
SET DATA(WHERE=(F9 EQ 1));
RUN;
PROC PRINT DATA=F91;
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F91;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F91;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F91;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F92*/
DATA F92;
SET DATA(WHERE=(F9 EQ 2));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F92;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F92;
TABLES SMHX SMPREG;
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RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F92;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F93*/
DATA F93;
SET DATA(WHERE=(F9 EQ 3));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F93;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F93;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F93;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F94*/
DATA F94;
SET DATA(WHERE=(F9 EQ 4));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F94;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F94;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F94;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F95*/
DATA F95;
SET DATA(WHERE=(F9 EQ 5));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F95;
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VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F95;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F95;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*TABLE FOR F10*/
/*F101*/
DATA F101;
SET DATA(WHERE=(F10 EQ 1));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F101;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F101;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F101;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F102*/
DATA F102;
SET DATA(WHERE=(F10 EQ 2));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F102;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F102;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F102;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F103*/
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DATA F103;
SET DATA(WHERE=(F10 EQ 3));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=F103;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F103;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F103;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F104*/
DATA F104;
SET DATA(WHERE=(F10 EQ 4));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=F104;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F104;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F104;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*F105*/
DATA F105;
SET DATA(WHERE=(F10 EQ 5));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=F105;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=F105;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=F105;
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VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*TABLE FOR M7*/
/*FM71*/
DATA M71;
SET DATA(WHERE=(M7 EQ 1));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M71;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M71;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M71;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M72*/
DATA M72;
SET DATA(WHERE=(M7 EQ 2));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M72;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M72;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M72;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M73*/
DATA M73;
SET DATA(WHERE=(M7 EQ 3));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M73;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
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PROC FREQ DATA=M73;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M73;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M74*/
DATA M74;
SET DATA(WHERE=(M7 EQ 4));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=M74;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M74;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M74;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M75*/
DATA M75;
SET DATA(WHERE=(M7 EQ 5));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=M75;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M75;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M75;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*TABLE FOR M8*/
/*FM81*/
DATA M81;
SET DATA(WHERE=(M8 EQ 1));
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RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M81;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M81;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M81;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M82*/
DATA M82;
SET DATA(WHERE=(M8 EQ 2));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M82;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M82;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M82;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M83*/
DATA M83;
SET DATA(WHERE=(M8 EQ 3));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATADATA=M83;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M83;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M83;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;
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/*M84*/
DATA M84;
SET DATA(WHERE=(M8 EQ 4));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=M84;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M84;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M84;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;

/*M85*/
DATA M85;
SET DATA(WHERE=(M8 EQ 5));
RUN;
/*MATERNAL*/
PROC UNIVARIATE DATA=M85;
VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL;
RUN;
PROC FREQ DATA=M85;
TABLES SMHX SMPREG;
RUN;
/*CHILD*/
PROC UNIVARIATE DATA=M85;
VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI;
RUN;
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